Clinical trial
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
NCT00382824 · Lahey Clinic, Other · Completed
Key facts
| NCT number | NCT00382824 |
|---|---|
| Title | Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP) |
| Official title | Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP): A Multicenter, Randomized, Placebo-controlled, Double Blind Study |
| Lead sponsor | Lahey Clinic, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Progressive Supranuclear Palsy |
| Intervention type | Dietary Supplement, Other |
| Interventions | Coenzyme Q10, Placebo |
| Enrollment | 61 |
| Start date | Sep 1, 2006 |
| Primary completion | Sep 1, 2013 |
| Completion | Jan 1, 2015 |
| First posted | Oct 2, 2006 |
| Last update posted | Aug 1, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: